"Combination drug therapy" trang 1 - tải miễn phí từ tailieunhanh
Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania

Variability of efavirenz plasma concentrations among pediatric HIV patients treated with efavirenz based combination antiretroviral therapy in Dar es Salaam, Tanzania
9    74    0
Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance

Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance
6    99    0
The effects of combination treatments on drug resistance in chronic myeloid leukaemia: An evaluation of the tyrosine kinase inhibitors axitinib and asciminib

The effects of combination treatments on drug resistance in chronic myeloid leukaemia: An evaluation of the tyrosine kinase inhibitors axitinib and asciminib
14    76    0
Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets

Statistical assessment and visualization of synergies for large-scale sparse drug combination datasets
15    53    1
Báo cáo y học:

Báo cáo y học: "Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial"
8    83    0
Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: A retrospective cohort study in South Korea

Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: A retrospective cohort study in South Korea
9    25    1
Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma
23    85    0
Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: A novel approach to screen for synergism

Synergisms of genome and metabolism stabilizing antitumor therapy (GMSAT) in human breast and colon cancer cell lines: A novel approach to screen for synergism
14    38    1
Combination therapy design for maximizing sensitivity and minimizing toxicity

Combination therapy design for maximizing sensitivity and minimizing toxicity
13    50    1
Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers

Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
11    37    1
ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition

ABBV-176, a PRLR antibody drug conjugate with a potent DNA-damaging PBD cytotoxin and enhanced activity with PARP inhibition
11    25    1
Salmonella overcomes drug resistance in tumor through P-glycoprotein downregulation

Salmonella overcomes drug resistance in tumor through P-glycoprotein downregulation
6    37    0
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects

Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
10    86    1
A computational study of hedgehog signalling involved in basal cell carcinoma reveals the potential and limitation of combination therapy

A computational study of hedgehog signalling involved in basal cell carcinoma reveals the potential and limitation of combination therapy
8    53    1
The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy

The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy
17    27    3
Combined use of dexmedetomidine and propofol in monitored anesthesia care: A randomized controlled study

Combined use of dexmedetomidine and propofol in monitored anesthesia care: A randomized controlled study
7    18    1
The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer

The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer
10    18    1
Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: Efects on cell death, self-renewal, and invasion

Targeting sphingolipid metabolism with the sphingosine kinase inhibitor SKI-II overcomes hypoxia-induced chemotherapy resistance in glioblastoma cells: Efects on cell death, self-renewal, and invasion
23    1    1
Regulation of voltage-gated potassium channels attenuates resistance of side-population cells to gefitinib in the human lung cancer cell line NCI-H460

Regulation of voltage-gated potassium channels attenuates resistance of side-population cells to gefitinib in the human lung cancer cell line NCI-H460
9    77    0
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models

Oral proteasome inhibitor with strong preclinical efficacy in myeloma models
10    59    1